ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FUNDADOR ADAJAR MD

Cardiovascular Disease

14,399

$742K

917
786 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $55

GUIDO LEON MD

Cardiovascular Disease

12,684

$744K

878
741 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $55

PEDRO ORTIZ MD

Cardiovascular Disease

9,261

$379K

1009
901 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $55

TERRY BOULWARE M.D.

Cardiovascular Disease

8,661

$677K

1152
1045 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$78
Average prescription price

Avg: $55

HAMID FEROZE MD

Cardiovascular Disease

8,088

$302K

586
541 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $55

CLAUDE BRACHFELD MD

Cardiovascular Disease

6,841

$366K

486
434 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $55

MAHAMADU FUSEINI MD

Cardiovascular Disease

6,726

$250K

594
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $55

MARY FRANKIS MD

Cardiovascular Disease

6,294

$353K

608
536 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $55

R STAMM MD

Cardiovascular Disease

5,808

$453K

766
711 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 22%

$78
Average prescription price

Avg: $55

ERIK FUNK MD

Cardiovascular Disease

5,750

$182K

421
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $55

NEAL SHADOFF MD

Cardiovascular Disease

5,188

$362K

519
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $55

MOHAMMAD HASSAN MD

Cardiovascular Disease

5,127

$204K

478
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $55

PATRICIA GURCZAK M.D.

Cardiovascular Disease

4,821

$187K

486
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $55

ROBERT TAYLOR MD

Cardiovascular Disease

4,682

$144K

766
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $55

ROBERT GRAOR M.D.

Cardiovascular Disease

4,542

$371K

526
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $55

MIHAELA BUJOI MD

Cardiovascular Disease

4,245

$251K

490
422 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $55

ROBERT ORCHARD MD

Cardiovascular Disease

4,182

$299K

506
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $55

JEROME YATSKOWITZ MD

Cardiovascular Disease

4,052

$214K

458
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $55

BARRY RAMO MD

Cardiovascular Disease

4,002

$202K

503
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $55

MICHAEL HARDING MD

Cardiovascular Disease

3,883

$262K

394
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $55

DANIEL FRIEDMAN MD

Cardiovascular Disease

3,882

$243K

459
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $55

BRENDAN CAVANAUGH MD

Cardiovascular Disease

3,790

$198K

490
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $55

ROBERT DUBROFF MD

Cardiovascular Disease

3,592

$276K

339
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $55

KATHLEEN ALLEN MD

Cardiovascular Disease

3,436

$233K

341
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $55

CRAIG CANNON M.D.

Cardiovascular Disease

3,411

$219K

446
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $55

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank